Effect of Caffeine on Gestational Diabetes Screening

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN90645333

Enrollment

Registered

2005-11-21

Start date

2005-10-01

Completion date

Unknown

Last updated

2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Nutritional, Metabolic, Endocrine Gestational Diabetes

Interventions

Effect of Caffeine versus placebo on 75 g oral glucose tolerance test results

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Pre-pregnancy body mass index (BMI) less than 30 kg/m^2 2. Non-smoking 3. No medications that could interfere with glucose uptake/metabolism (i.e. insulin, anti-hyperglycemics) 4. No known medical/obstetrical complications

Exclusion criteria

Exclusion criteria: As per inclusion criteria

Design outcomes

Primary

Measure	Time frame
Maternal blood glucose	—

Secondary

Measure	Time frame
1. Maternal plasma insulin, C-peptide, catecholamines, methylxanthines, free fatty acids, glycerol, lactate, and electrolytes 2. Fetal heart rate baseline and accelerations	—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026